Coverage / NYSE:ELV / Trade Card

NYSE:ELV

Elevance Health Inc

BUY Analysis generated 2026-10-04 Market data as of 2026-11-12 Market data 3 days old USD 429.90 Healthcare - Medical - Healthcare PlansREDUCE ZONE
ACTIONABLEMethodology gates passed
66

Position levels

Currenttoday
USD 429.90
Buy <=wait / entry
USD 340.00
Trim >=take some off
USD 420.00
Thesis breakA 2027 EPS guidance raise fails to materialise, or an adverse regulatory action ...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case33%100 / 10033.0
Base case51%62 / 10031.6
Bear case16%10 / 1001.6
Weighted conviction66 / 100 - BUY

Top risks

  • Raised full-year 2026 adjusted diluted EPS guidance multiple times to at least $27
  • Q4 2025 operating revenue $49.3B (+10% YoY) and full-year 2025 revenue $197.6B (+13% YoY)
  • Reaffirmed path to at least 12% adjusted EPS growth in 2027
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.

\n